News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News HFSA 2024 EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER Caitlin E. Cox October 03, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes Michael O'Riordan March 15, 2024